Treating the speech disorder in Parkinson's disease online

The Lee Silverman Voice Treatment (LSVT) has been shown to be highly effective in treating the speech disorder in Parkinson's Disease (PD). However, patient access to this treatment remains limited in Australia, due to availability of speech pathologists, patient mobility and distance issues. We have investigated the feasibility and effectiveness of an Internet-based telerehabilitation application (eREHAB) for the delivery of the LSVT to persons with PD and disordered speech. Ten participants with PD and dysarthria were treated online with the LSVT for a total of 16 sessions. There were significant improvements in sound pressure levels for vowel prolongation, reading and conversational monologue (P<0.01), pitch range (P<0.05) and in perceptual features of pitch and loudness variability, loudness level (P<0.01) and breathiness (P<0.05). A participant satisfaction questionnaire indicated that 70% of participants expressed overall satisfaction with the online treatment. Telerehabilitation was feasible and effective in delivering the LSVT to people with PD.

[1]  L. Hartelius,et al.  Comparability of Perceptual Analysis of Speech Characteristics in Australian and Swedish Speakers with Multiple Sclerosis , 2003, Folia Phoniatrica et Logopaedica.

[2]  J Kreiman,et al.  Validity of rating scale measures of voice quality. , 1998, The Journal of the Acoustical Society of America.

[3]  L. Ramig,et al.  Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. , 1995, Journal of voice : official journal of the Voice Foundation.

[4]  L. Raming,et al.  Voice treatment for patients with Parkinson desease: Development of an approach and preliminary efficacy data , 1994 .

[5]  S. Countryman,et al.  Intensive speech treatment for patients with Parkinson's disease , 1996, Neurology.

[6]  L. Ramig,et al.  Current Perspectives on the Lee Silverman Voice Treatment (LSVT) for Individuals With Idiopathic Parkinson Disease , 2002 .

[7]  S. Sapir,et al.  Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. , 2001, Journal of voice : official journal of the Voice Foundation.

[8]  E S Luschei,et al.  Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging , 1998, Neurology.

[9]  L. Ramig,et al.  Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease. , 1996, Journal of speech and hearing research.

[10]  S. Countryman,et al.  Comparison of two forms of intensive speech treatment for Parkinson disease. , 1995, Journal of speech and hearing research.

[11]  A. Aronson,et al.  Clusters of deviant speech dimensions in the dysarthrias. , 1969, Journal of speech and hearing research.

[12]  L. O. Ramig,et al.  4. The role of phonation in speech intelligibility: A review and preliminary data from patients with Parkinson's disease , 1992 .

[13]  S. Countryman,et al.  Intensive voice treatment (LSVT®) for patients with Parkinson's disease: a 2 year follow up , 2001 .

[14]  J. Logemann,et al.  Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. , 1978, The Journal of speech and hearing disorders.

[15]  Annie J. Hill,et al.  Research into telehealth applications in speech-language pathology , 2002, Journal of telemedicine and telecare.